02.12.26 -- With CDMOs Like This, Who Needs Biotechs?

Taking a molecule from drug substance to drug product often falters at the handoff. In this webinar, KBI Biopharma and Argonaut Manufacturing Services share how integrated CDMO-to-fill-finish partnerships eliminate silos, streamline quality, and reduce risk. Join a candid fireside chat on the top 10 quality challenges and proven solutions that cut timelines by 2–3 months from development through late-stage commercialization. Click here to learn more.

A sponsor’s commitment to rigorous impurity control throughout manufacturing is vital to ensuring patient safety. E&Ls, nitrosamines, and PFAS are among the most critical impurities to test for.

Fast‑Track pharmaceutical analytical services, identify and resolve manufacturing failures, reduce delays, control costs, and safeguard patient safety through accurate forensic analysis.

Gain expert insights on mitigating risks in global pharmaceutical manufacturing by learning from Joon Chang and Tracey Partington’s decades of industry experience.

Scaling trials across sites can lock in supply risk early. Learn how biologic variability, long lead times, and multisite complexity threaten trials and how to spot warning signs fast.

Discover a practical roadmap for replacing animal tests with advanced molecular methods, as well as how regulatory updates and innovative technologies are shaping a sustainable future.

Developing robust, scalable microbial fermentation depends on optimizing growth and expression phases through oxygen transfer, fine-tuning of nutrient delivery, and induction of protein expression.

As capacity expands and capabilities mature, CDMOs with global scale and advanced injectable expertise are becoming critical partners for bringing complex sterile drug products to market.

This generic drug–device combination is designed for usability and regulatory compliance, demonstrating performance comparable to the reference device.

Adopt QbD principles in your biologics development and manufacturing process to ensure consistent product quality, mitigate risks, and align with patient safety and commercial success goals.

To accelerate COVID-19 vaccine production, a leading biologics contract manufacturer sought high-speed labeling machines that could be rapidly deployed.

Explore how advanced machine learning and data analytics are revolutionizing biopharmaceutical manufacturing and driving operational excellence.

View examples of visible particle identification and the root cause investigation, along with a discussion of the performance of additional troubleshooting using advanced and innovative technologies.

Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization. 

Discover how knowledge of microbial processes and process characterization understanding can be used to design targeted BLA programs while managing risks.

Uncover how DNA barcoding enables rapid screening of vast chemical space in early drug discovery, as well as how DEL platforms test billions of compounds efficiently.

Take a virtual tour of a new facility to explore advanced features and assimilate how we enable scalable, sustainable performance.

We use our bio-logic brilliance to unravel the complexities of ADCs — empowering companies to accelerate development, enhance manufacturing efficiency, and deliver life-changing therapies.

Beyond basic storage, our comprehensive services deliver fully compliant, state-of-the-art environments where samples are meticulously cataloged, tracked, and maintained with precision.

Site head Bill Hermans showcases our facility's specialized capabilities in Hopkinton, Massachusetts, and shares how our team serves as a true scientific partner to clients.

Accelerate vaccine development with integrated services, supporting all common vaccine types from discovery through IND. Leverage expertise in immunogenicity, dose-response, and efficacy studies.